"Vitamin D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
| Descriptor ID |
D014807
|
| MeSH Number(s) |
D04.210.500.812.768
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitamin D".
Below are MeSH descriptors whose meaning is more specific than "Vitamin D".
This graph shows the total number of publications written about "Vitamin D" by people in this website by year, and whether "Vitamin D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 3 | 4 | 7 |
| 2008 | 4 | 2 | 6 |
| 2009 | 2 | 3 | 5 |
| 2010 | 7 | 2 | 9 |
| 2011 | 3 | 4 | 7 |
| 2012 | 6 | 3 | 9 |
| 2013 | 8 | 4 | 12 |
| 2014 | 5 | 4 | 9 |
| 2015 | 13 | 3 | 16 |
| 2016 | 8 | 3 | 11 |
| 2017 | 9 | 2 | 11 |
| 2018 | 4 | 5 | 9 |
| 2019 | 5 | 3 | 8 |
| 2020 | 5 | 5 | 10 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitamin D" by people in Profiles.
-
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study. Mult Scler Relat Disord. 2023 Mar; 71:104523.
-
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Miner Res. 2023 01; 38(1):14-25.
-
Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep. 2022 11 12; 12(1):19397.
-
Effects of Vitamin D Supplementation on Adipose Tissue Inflammation and NF-?B/AMPK Activation in Obese Mice Fed a High-Fat Diet. Int J Mol Sci. 2022 Sep 18; 23(18).
-
Vitamin D and Parathyroid Hormone Levels in CKD. Am J Kidney Dis. 2023 01; 81(1):122-124.
-
Exposure to arsenic and level of Vitamin D influence the number of Th17 cells and production of IL-17A in human peripheral blood mononuclear cells in adults. PLoS One. 2022; 17(4):e0266168.
-
Follicular keratosis of the face in pediatric patients of color. Pediatr Dermatol. 2022 Mar; 39(2):231-235.
-
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2022 01 01; 107(1):e372-e385.
-
The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord. 2021 Nov 20; 21(1):232.
-
Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2021 03 01; 4(3):e214117.